Johnson & Johnson
JNJ · NYSE · Healthcare
253.01USD−0.90▼ −0.35%
Prices delayed 15 minutes
Key data
- Market cap
- 609.73B USD
- P/E ratio
- 22.94
- EPS (trailing 12 months)
- 11.03 USD
- Revenue (trailing 12 months)
- 94.19B USD
- Dividend yield
- 2.09%
- Price-to-book
- 7.18
- Beta (volatility)
- -0.20
- Average volume (20 sessions)
- 7.23M
52-week low and high
184.66281.07
Latest news & analysis
EarningsJohnson & Johnson achieves 5.9% sales growth in third quarter and raises earnings guidanceJohnson & Johnson announced 5.9% sales growth in the third quarter 2026, adjusted earnings per share of $2.59, and raised its full-year earnings per share guidance to $11.10.Why it movedJohnson & Johnson stock falls 5.8% despite raising full-year earnings guidanceJohnson & Johnson stock fell 5.8% to close at $248.57, in a session coinciding with the company's announcement of third quarter results and raising of adjusted earnings per share guidance for the full year to $11.10.
For information only; not a recommendation to buy or sell. Prices may be delayed up to 15 minutes.